MedTrace Logo

rhBMP-2 in Cervical Arthrodesis

NCT02178605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-10-12

No results posted yet for this study

Summary

This prospective study will investigate the use of recombinant human bone morphogenetic protein (rhBMP-2) in the current surgical standard of care for cervical spine pathology. Specifically, the outcomes of three forms of cervical fusion will be investigated:

1. Anterior cervical fusion with rhBMP-2, allograft corticocancellous bone as an interbody device, and anterior cervical plate fixation.
2. Posterior cervical fusion with rhBMP-2, local bone graft, with or without posterior screw fixation.
3. A combination of the previous two approaches: a combined anterior-posterior cervical fusion with rhBMP-2.

Conditions

  • Cervical Arthrodesis

Interventions

PROCEDURE

Cervical arthrodesis with rhBMP-2

Cervical arthrodesis with rhBMP-2

Sponsors & Collaborators

  • Virginia Spine Institute

    lead OTHER

Principal Investigators

  • Brian R Subach, MD · Virginia Spine Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178605 on ClinicalTrials.gov